Retrospective Cohort Study
Copyright ©The Author(s) 2020.
World J Gastrointest Oncol. Sep 15, 2020; 12(9): 992-1004
Published online Sep 15, 2020. doi: 10.4251/wjgo.v12.i9.992
Table 1 Correlation analysis of clinicopathological characteristics and lymphatic and/or blood vessel invasion (LBVI) in advanced gastric cancer
VariableLVBI
χ2P value
PresenceAbsence
Gender0.0110.916
Male330 (74.7)1609 (74.5)
Female112 (25.3)553 (25.5)
Age (yr)2.2000.138
< 60233 (52.7)1056 (48.8)
≥ 60209 (47.3)1106 (51.2)
Borrmann type17.2940.001
I17 (3.8)106 (4.9)
II95 (21.5)369 (17.1)
III250 (56.6)1413 (65.4)
IV80 (18.1)274 (12.7)
Tumor location33.630< 0.001
Upper third28 (6.3)273 (12.6)
Middle third62 (14.0)339 (15.7)
Lower third220 (49.8)1135 (52.5)
Whole stomach132 (29.9)415 (19.2)
Tumor size (mm)16.077< 0.001
< 50118 (26.7)793 (36.7)
≥ 50324 (73.3)1369 (63.3)
Histologic grade15.084< 0.001
Well129 (29.2)843 (39.0)
Poor313 (70.8)1319 (61.0)
pT category213.269< 0.001
T229 (6.6)294 (13.6)
T3212 (48.0)358 (16.6)
T4a171 (38.7)1269 (58.7)
T4b30 (6.8)241 (11.1)
pN category96.976< 0.001
N044 (10.0)522 (24.1)
N157 (12.9)409 (18.9)
N295 (21.5)529 (24.5)
N3246 (55.7)702 (32.5)
Surgical approach37.183< 0.001
Proximal gastrectomy23 (5.2)211 (9.8)
Distal gastrectomy235 (53.2)1351 (62.5)
Total gastrectomy184 (41.6)600 (27.8)
Combined resection1.2510.263
Presence19 (4.3)70 (3.2)
Absence423 (95.7)2092 (96.8)